Medpace Holdings (MEDP) Return on Capital Employed (2016 - 2026)
Medpace Holdings (MEDP) reported Return on Capital Employed of 79.56% for Q1 2026, up 2752.0% on a YoY basis from 2.79% in Q1 2025, and down 22.59% quarter-over-quarter from 102.77% in Q4 2025.
Medpace Holdings (MEDP) Return on Capital Employed (2016 - 2026) Analysis & Trends
Medpace Holdings has reported Return on Capital Employed for 11 years, with the latest figure at 79.56% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 2752.0% year-over-year to 79.56%; the trailing twelve-month figure through Mar 2026 stood at 79.56% (up 2752.0% YoY), and the FY2025 full-year result was 77.03%, up 1932.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 79.56%, down from 102.77% in the prior quarter.
- The five-year high for Return on Capital Employed was 133.99% in Q3 2025, with the low at 23.32% in Q1 2022.
- Historically, Return on Capital Employed has averaged 61.36% across 5 years, with a median of 52.04% in 2025.
- Annual changes were most pronounced in 2024 — Return on Capital Employed plunged 1501 bps — and 2025, when it jumped 9143 bps.
- Medpace Holdings' Return on Capital Employed stood at 51.9% in 2022, then climbed by 0 bps to 52.09% in 2023, then decreased by 13 bps to 45.23% in 2024, then jumped by 127 bps to 102.77% in 2025, then declined by 23 bps to 79.56% in 2026.
- The last three Return on Capital Employed figures came in at 79.56% (Q1 2026), 102.77% (Q4 2025), and 133.99% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 4.82% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 8.12% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 6.26% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 67.98% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 14.57% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -3.63% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 10.24% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 16.90% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 45.73% |
| 10 | Medpace Holdings | 13.31 Bn | 12.66 Bn | 196.33 Mn | 79.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.56% |
| Dec 31, 2025 | 102.77% |
| Sep 30, 2025 | 133.99% |
| Jun 30, 2025 | 92.89% |
| Mar 31, 2025 | 52.04% |
| Dec 31, 2024 | 45.23% |
| Sep 30, 2024 | 42.55% |
| Jun 30, 2024 | 44.11% |
| Mar 31, 2024 | 46.08% |
| Dec 31, 2023 | 52.09% |
| Sep 30, 2023 | 54.48% |
| Jun 30, 2023 | 58.09% |
| Mar 31, 2023 | 61.09% |
| Dec 31, 2022 | 51.90% |
| Sep 30, 2022 | 51.31% |
| Jun 30, 2022 | 51.67% |
| Mar 31, 2022 | 23.32% |
| Dec 31, 2021 | 18.71% |
| Sep 30, 2021 | 19.75% |
| Jun 30, 2021 | 19.38% |